Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions

• Daniele Generali,
• Daniele Generali,
• Rossana Berardi,
• Michele Caruso,
• Marina Cazzaniga,
• Marina Cazzaniga,
• Ornella Garrone,
• Ida Minchella,
• Ida Paris,
• Carmine Pinto,
• Sabino De Placido

Affiliations

Daniele Generali

Breast Cancer Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy

Daniele Generali

Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy

Rossana Berardi

Medical Oncology, Azienda Ospedaliera Universitaria (AOU) delle Marche, University Politecnica delle Marche, Ancona, Italy

Michele Caruso

Humanitas Istituto Clinico Catanese, Breast Centre Humanitas Catania, Catania, Italy

Marina Cazzaniga

School of Medicine and Surgery University of Milano Bicocca, Milan, Italy

Marina Cazzaniga

Phase 1 Research Unit, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy

Ornella Garrone

Medical Oncology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Ida Minchella

Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy

Ida Paris

Department of Woman and Child Health and Public Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy

Carmine Pinto

0Medical Oncology Unit, Comprehensive Cancer Centre, Azienda Unità Sanitaria Locale - Istituto di Ricerca e Cura a Carattere Scientifico (AUSL-IRCCS) di Reggio Emilia, Reggio Emilia, Italy

Sabino De Placido

1Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy